A bankruptcy court this week approved the $305 million sale of genetics testing firm 23andMe to a nonprofit organization led by the company's former CEO Anne Wojcicki, the company announced. The ...

NEW YORK (AP) — Anne Wojcicki's bid to buy 23andMe ... Walsh on Friday, marks the end of a monthslong bidding war between TTAM and Regeneron Pharmaceuticals — a biotech company that had previously ...

Regeneron, which forfeited a $15.1 million earnest-money deposit made with its initial bid, reportedly had decided not to try to top the Wojcicki group's bid. Page 1 2 3 View All ...

Regeneron Pharmaceuticals (NASDAQ:REGN) has reportedly declined to submit a higher bid for 23andMe (OTC:MEHCQ) after a non-profit led by the company’s co-founder and former CEO Anne Wojcicki ...

Anne Wojcicki's winning bid to reclaim control of 23andMe doesn't necessarily end the fight over what happens to the DNA of 15 million people collected by the bankrupt consumer genomics company.

Anne Wojcicki’s nonprofit gets court approval to buy 23andMe for $305 million Under the deal, TTAM will acquire 23andMe’s signature “Personal Genome Service” provided through the company ...

Anne Wojcicki's nonprofit TTAM acquires 23andMe for $305 million, ending the gene-testing pioneer's bankruptcy saga. The deal still faces state regulators' objections over genetic data control.

NEW YORK (AP) — Anne Wojcicki's bid to buy 23andMe, the genetic testing company she cofounded nearly 20 years ago, has received the court greenlight.

Anne Wojcicki’s nonprofit gets court approval to buy 23andMe for $305 million Under the deal, TTAM will acquire 23andMe’s signature “Personal Genome Service” provided through the company ...

NEW YORK (AP) — Anne Wojcicki’s bid to buy 23andMe, the genetic testing company she cofounded nearly 20 years ago, has received the court greenlight. West Hartford wine bar closing but not ...

Anne Wojcicki's nonprofit, TTAM Research Institute, has received court approval to acquire 23andMe, the genetic testing company she co-founded. The $305 million deal follows 23andMe's Chapter 11 ...